|
|
| Biotechnology, 42 |
FPUYGX |
9/12/2018 |
| 30309X425 |
| 30309X441 (Fee) |
|
| 30309X433 |
| 30309X458 (Fee) |
|
2 Year |
|
|
| Dividend Growth, 23 |
FVTROX |
9/12/2018 |
| 30309X300 |
| 30309X326 (Fee) |
|
| 30309X318 |
| 30309X334 (Fee) |
|
5 Year |
|
|
| High Dividend Equity Allocation, 29 |
FHZQLX |
9/12/2018 |
| 30309X466 |
| 30309X482 (Fee) |
|
| 30309X474 |
| 30309X490 (Fee) |
|
2 Year |
|
|
| REIT Growth & Income Select, 47 |
FCAYPX |
9/12/2018 |
| 30309X342 |
| 30309X367 (Fee) |
|
| 30309X359 |
| 30309X375 (Fee) |
|
2 Year |
|
|
| Strategic Dividend Select, 34 |
FEJSCX |
9/12/2018 |
| 30309X383 |
| 30309X409 (Fee) |
|
| 30309X391 |
| 30309X417 (Fee) |
|
2 Year |
|
|
| Core Three Closed-End Allocation, 35 |
FJECAX |
9/13/2018 |
| 30310A349 |
| 30310A364 (Fee) |
|
| 30310A356 |
| 30310A372 (Fee) |
|
2 Year |
|
|
| Senior Loan & Limited Duration Opportunities Closed-End, 58 |
FHBOLX |
9/13/2018 |
| 30310C105 |
| 30310C121 (Fee) |
|
| 30310C113 |
| 30310C139 (Fee) |
|
15 Month |
|
|
| Strategic Income Advantage Opportunity, Closed-End, 9 |
FVNWUX |
9/13/2018 |
| 30310A182 |
| 30310A208 (Fee) |
|
| 30310A190 |
| 30310A216 (Fee) |
|
15 Month |
|
|
| Strategic Income Select Closed-End, 36 |
FVIOMX |
9/13/2018 |
| 30309Y803 |
| 30309Y829 (Fee) |
|
| 30309Y811 |
| 30309Y837 (Fee) |
|
2 Year |
|
|
| Automated Quantitative Analysis, 17 |
FAPSTX |
9/14/2018 |
| 30309U827 |
| 30309U843 (Fee) |
|
| 30309U835 |
| 30309U850 (Fee) |
|
2 Year |
|
|
| Dorsey Wright Relative Strength Dividend, 32 |
FRIESX |
9/14/2018 |
| 30309Y605 |
| 30309Y621 (Fee) |
|
| 30309Y613 |
| 30309Y639 (Fee) |
|
15 Month |
|
|
| Energy Opportunity, 3 |
FVERIX |
9/14/2018 |
| 30309Y647 |
| 30309Y662 (Fee) |
|
| 30309Y654 |
| 30309Y670 (Fee) |
|
15 Month |
|
|
| Financials Opportunity, 3 |
FYNRPX |
9/14/2018 |
| 30309Y720 |
| 30309Y746 (Fee) |
|
| 30309Y738 |
| 30309Y753 (Fee) |
|
15 Month |
|
|
| International Capital Strength Opportunity, 6 |
FNTHMX |
9/14/2018 |
| 30309X508 |
| 30309X524 (Fee) |
|
| 30309X516 |
| 30309X532 (Fee) |
|
15 Month |
|
|
| SMid Capital Strength Opportunity, 6 |
FWRYOX |
9/14/2018 |
| 30309X540 |
| 30309X565 (Fee) |
|
| 30309X557 |
| 30309X573 (Fee) |
|
15 Month |
|
|
| Tactical Alpha, 18 |
FZLQNX |
9/14/2018 |
| 30309W104 |
| 30309W120 (Fee) |
|
| 30309W112 |
| 30309W138 (Fee) |
|
15 Month |
|
|
| Capital Strength, 44 |
FSGIVX |
9/17/2018 |
| 30309W302 |
| 30309W328 (Fee) |
|
| 30309W310 |
| 30309W336 (Fee) |
|
2 Year |
|
|
| Market Strength Allocation Opportunity, 6 |
FQJCEX |
9/17/2018 |
| 30309W260 |
| 30309W286 (Fee) |
|
| 30309W278 |
| 30309W294 (Fee) |
|
15 Month |
|
|
| Market Strength Allocation Select, 33 |
FTKYRX |
9/17/2018 |
| 30309W344 |
| 30309W369 (Fee) |
|
| 30309W351 |
| 30309W377 (Fee) |
|
2 Year |
|
|
| Strategic Income Advantage Select Closed-End, 78 |
FRCBPX |
9/17/2018 |
| 30310C626 |
| 30310C642 (Fee) |
|
| 30310C634 |
| 30310C659 (Fee) |
|
2 Year |
|
|
| Tactical Income, 54 |
FMADSX |
9/17/2018 |
| 30309Y688 |
| 30309Y704 (Fee) |
|
| 30309Y696 |
| 30309Y712 (Fee) |
|
2 Year |
|
|
| Balanced Income Equity and ETF Opportunity, 6 |
FNPLUX |
9/18/2018 |
| 30310A141 |
| 30310A166 (Fee) |
|
| 30310A158 |
| 30310A174 (Fee) |
|
15 Month |
|
|
| Capital Strength Buy-Write, 41 |
FOIMDX |
9/19/2018 |
| 30310A620 |
| 30310A638 (Fee) |
|
|
15 Month |
|
|
| Equity Closed-End, 50 |
FGYBHX |
9/19/2018 |
| 30310A109 |
| 30310A125 (Fee) |
|
| 30310A117 |
| 30310A133 (Fee) |
|
2 Year |
|
|
| Mega-Cap, 50 |
FVRGNX |
9/19/2018 |
| 30310A646 |
| 30310A661 (Fee) |
|
| 30310A653 |
| 30310A679 (Fee) |
|
2 Year |
|
|
| Preferred Income, 96 |
FKYJGX |
9/19/2018 |
| 30310A703 |
| 30310A729 (Fee) |
|
| 30310A711 |
| 30310A737 (Fee) |
|
2 Year |
|
|
| S&P Dividend Aristocrats Buy-Write, 2 |
FBZVAX |
9/19/2018 |
| 30310A687 |
| 30310A695 (Fee) |
|
|
15 Month |
|
|
| Sabrient Baker's Dozen, September 2018 |
FQNWMX |
9/20/2018 |
| 30309W187 |
| 30309W203 (Fee) |
|
| 30309W195 |
| 30309W211 (Fee) |
|
13 Month |
|
|
| Silicon Valley Opportunity, 1 |
FBGYHX |
9/20/2018 |
| 30310A745 |
| 30310A760 (Fee) |
|
| 30310A752 |
| 30310A778 (Fee) |
|
15 Month |
|
|
| Tax Exempt Municipal Income, Intermediate, 36 |
FECUPX |
9/20/2018 |
| 33741B225 |
| 33741B233 (Wrap) |
|
|
TBD |
|
|